Copper Acetate Manufacturers(WSDTY) proposed the extracellular content and release of IL-1α, IL-8, HSPA1A and FOSL1 were determined using Copper Acetate. The expression of FOSL1 in the culture medium for all the samples were undetectable. The concentrations of IL-1α, IL-8 and HSPA1A released after treatment with various compounds were presented. At the two tested concentrations, treatment with both GHK and GHK-Cu did not significantly increase the IL-1α, IL-8 and HSPA1A protein levels. For the treatment groups with CuCl2 and Cu(OAc)2, copper compounds had a positive correlation with the protein level regulated.
CuCl2 didn’t cause any change in the IL-1α, IL-8 and HSPA1A protein levels at the concentration of 58μM, while the protein levels upregulated significantly with 580μM CuCl2 treatment. On the other hand, the IL-1α, IL-8 and HSPA1A protein levels were increased significantly with 580?μM Cu(OAc)2 treatment as well. At the same concentration of 580μM, Cu(OAc)2 induced a higher upregulation of IL-1α than CuCl2, while CuCl2 induced a higher upregulation of IL-8, HSPA1A and FOSL1 than Cu(OAc)2. Furthermore, 58μM Cu(OAc)2 also upregulated the IL-1α expression significantly.
Wujiang Weishida Copper Technology Co.,Ltd. has 12,000 square meters of production base. By virtue of their sincere cooperation, reciprocity of the business philosophy for the industry users around the country to provide high-quality non-ferrous metal products. Weishida specializes in producing cuprous chloride, basic copper carbonate, copper acetate, copper oxide, copper sulfate. Our company has established a perfect quality assurance system, quality inspection and testing equipment, testing, testing and technology development strength, to ensure the stability of product quality, fully able to meet the pre-market after-sales service to provide users with the need.
Click 8-hydroxyquinoline Copper to learn about more information